B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma

NCT03246750 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Extranodal NK/T-cell Lymphoma

Interventions

DRUG: B-MAD chemotherapy

Sponsor

The Thai Lymphoma Study Group

Collaborators

[object Object]